Soleno Therapeutics (SLNO) Q4 2023 Earnings

6MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.95
-0.72
-0.5
-0.27

Details

Expected EPS
-0.273333
Actual EPS
-0.33
Surprise EPS
-0.06
Surprise Percent
+20.73%

Description

Soleno Therapeutics (SLNO) has reported earnings of -0.33 per share for Q4 2023.

0 Comments

Share your thoughts